Join us for an important webinar in collaboration with our national partner, Slater and Gordon, as we explore mesothelioma - a rare and aggressive cancer linked to asbestos exposure.
In this webinar with CNSA's legal partner Slater and Gordon, we cover the current landscape and trends including atypical exposures, the role of the lawyer, and entitlements and compensation available.
This webinar is the first of our Australian Cancer Nursing and Navigation Program (ACNNP) Series and offers an opportunity for the Cancer Nursing workforce to receive an update on the ACNNP - All-Cancer Nurses Stream and the proposed Model of Care developed by the McGrath Foundation.
This webinar offers an opportunity for the Cancer Nursing workforce to receive an update on the Australian Cancer Nursing and Navigation Program (ACNNP) - Specialist Support Services stream.
In this webinar, our experts speakers took participants through Strategies for Adverse Event Management in Breast Cancer and Identifying and Managing Immune Mediated Endocrinopathies
The Cancer Nurses Society of Australia (CNSA) is proud to partner with the Clinical Oncology Society of Australia (COSA) to present an insightful webinar.
This webinar offers an opportunity for the Cancer Nursing workforce to receive an update on the Australian Cancer Nursing and Navigation Program (ACNNP) - including operational priorities, key implementation activity, referral pathways, and core roles and responsibilities.
This webinar provides practical insights into recognising, assessing, and managing cancer-related fatigue. Learn evidence-based strategies including medical, exercise, and lifestyle interventions, with a focus on real-world application and multidisciplinary care
This session will cover diagnosis, treatment and support pathways for women diagnosed with cancer during pregnancy or postpartum, as well as the development of Australia’s first sector-wide PAC initiative.
This session is essential for nurses looking to build confidence in public health and primary prevention, and to better advocate for equity in cancer outcomes.